NCT02565888View on ClinicalTrials.gov

A Drug-drug Interaction Study Between Daclatasvir and Atazanavir/Ritonavir or Atazanavir/Cobicistat

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Hepatitis CHIV
Interventions
DRUG

Daclatasvir

DRUG

Atazanavir

DRUG

Ritonavir

DRUG

Cobicistat

Trial Locations (1)

Unknown

CRCN, Radboud University Medical Center, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT02565888 - A Drug-drug Interaction Study Between Daclatasvir and Atazanavir/Ritonavir or Atazanavir/Cobicistat | Biotech Hunter | Biotech Hunter